Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 37 of 59, showing 10 Applications out of 584 total, starting on record 361, ending on 370

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

361.

ECCT/20/04/02   PROSYNK Study
    A 4-arm, open-label, individually randomized, controlled, phase-2, study of a probiotic and two synbiotics in young children in western Kenya.   
Principal Investigator(s)
1. Stephen Allen
Site(s) in Kenya
1. Homa Bay County Referral Hospital (Homa Bay county)
2. Siaya County Referral Hospital (Siaya county)
3. Migori County Referral Hospital (Migori county)
4. Rongo Sub-County Hospital (Migori county)
5. Rachuonyo Sub County Hospital (Homa Bay county)
6. Kendu Bay Sub-County Hospital (Homa Bay county)
7. Ahero County Hospital (Kisumu county)
8. Rabuor Sub-County Hospital (Kisumu county)
9. Akala Sub-County Hospital (Siaya county)
10. Bondo Sub-County Hospital (Siaya county)
 
05-08-2020 View

362.

ECCT/19/11/05   Point-of-care Urine Monitoring of Adherence (PUMA)
    Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP   Pilot trial to examine the feasibility, acceptability and impact on longer-term adherence of an intervention using a new urine-based tenofovir adherence assay       
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR PHRD (THIKA) PROJECT
 
15-04-2020 View

363.

ECCT/19/11/03   A Pilot BE study for Enalpril 5mg
    A bioequivalent pilot study of a locally-produced brand of enalapril tablets:  a key step towards implementation of bioequivalent study regulatory requirements in East Africa   
Principal Investigator(s)
1. Simon Njoroge Njenga
Site(s) in Kenya
Kenya Medical Research Institute
 
09-04-2020 View

364.

ECCT/19/11/04   Second line switch to Dolutegravir (2SD) study
    Switching Treatment-Experienced, Integrase Inhibitor-Naïve, Virally Suppressed HIV-1 Infected Adults from Ritonavir boosted Protease Inhibitors to Dolutegravir: An Open-Label Randomized Controlled Trial               
Principal Investigator(s)
1. Loice Achieng
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
3. Thika Level 5 Hospital (Kiambu county)
4. Kiambu Level 5 Hospital (Kiambu county)
 
23-12-2019 View

365.

ECCT/19/11/02   PrEP and dPEP
    PrEP and dPEP: Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis   
Principal Investigator(s)
1. Dr.Elizabeth Bukusi Ann Bukusi
Site(s) in Kenya
KEMRI/CMR/RCTP Kisumu-Lumumba Sub-County Hospital
 
31-01-2020 View

366.

ECCT/19/12/01   BOHEMIA PK400
    Mosquitocidal effect and pharmacokinetics of different ivermectin dose regimens in preparation for BOHEMIA cluster randomized controlled trial.   
Principal Investigator(s)
1. Marta Ferreira Maia
Site(s) in Kenya
Kilifi
 
01-04-2020 View

367.

ECCT/19/10/03   Smoking Cessation Study for PLHIV
    Optimizing Smoking Cessation Interventions For People Living With Human Immunodeficiency Virus in Nairobi, Kenya   
Principal Investigator(s)
1. Dr. Seth Scott Himelhoch Seth Scott Himelhoch
Site(s) in Kenya
Mathari National Teaching and Referral Hospital
 
03-04-2020 View

368.

ECCT/19/10/01   AMC-099
    A Randomized, Placebo-Controlled Trial of HPV Vaccination to Reduce Cervical High-Grade Squamous Intraepithelial Lesions among HIV-Infected Women Participating in an HPV Test-and-Treat Program (COVENANT)   
Principal Investigator(s)
1. ELKANAH ORANGO OMENGE
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTER
 
01-04-2020 View

369.

ECCT/19/10/02   AMC-100
    A Phase II Multicenter Study of Pomalidomide Monotherapy in HIV-Positive Individuals with Kaposi Sarcoma (KS) in Sub-Saharan Africa (SSA)   
Principal Investigator(s)
1. NAFTALI WISINDI BUSAKHALA
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTER
 
01-04-2020 View

370.

ECCT/19/08/01   Use of malaria infection by injection to study malaria transmission
    Safety and feasibility of a malaria transmission model in semi-immune Kenyan adults using Plasmodium falciparum sporozoites   
Principal Investigator(s)
1. Melissa Kapulu
2. Philip Bejon
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya.
 
15-11-2019 View